{{Rsnum
|rsid=3916966
|Gene=DAOA-AS1
|Chromosome=13
|position=105458546
|Orientation=plus
|GMAF=0.4293
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 39.3 | 50.0 | 10.7
| HCB | 19.7 | 36.5 | 43.8
| JPT | 6.2 | 48.2 | 45.5
| YRI | 61.9 | 34.0 | 4.1
| ASW | 52.6 | 43.9 | 3.5
| CHB | 19.7 | 36.5 | 43.8
| CHD | 14.0 | 44.9 | 41.1
| GIH | 34.7 | 48.5 | 16.8
| LWK | 47.3 | 45.5 | 7.3
| MEX | 32.8 | 46.6 | 20.7
| MKK | 61.3 | 29.0 | 9.7
| TSI | 35.3 | 48.0 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=20667145
|Title=The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach
|OA=1
}}

{{PMID Auto
|PMID=22122005
|Title=DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes
}}

{{PMID Auto
|PMID=16842973
|Title=No association of G72 and D-amino acid oxidase genes with schizophrenia.
}}

{{PMID Auto
|PMID=17179078
|Title=G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies.
|OA=1
}}

{{PMID Auto
|PMID=18023149
|Title=Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis.
|OA=1
}}

{{PMID Auto
|PMID=18165970
|Title=Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder.
}}

{{PMID Auto
|PMID=18466879
|Title=Association of a nonsynonymous variant of DAOA with visuospatial ability in a bipolar family sample.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}